News
Evidence suggests possible RAS-blocker benefit in COVID-19 patients
April 16, 2020
Animal findings and physiologic mechanisms suggest RAS system inhibitors may benefit COVID-19 patients, another reason not to stop these drugs.
News
No hydroxychloroquine benefit in small, randomized COVID-19 trial
April 16, 2020
Two experts caution that because of confounding, the trial is unable to answer convincingly the question of whether HCQ can benefit COVID-19 patients.
Opinion
COVID-19 mythconceptions
April 16, 2020
We are in a position where we need to take in what we can and assess the best data available.
News
Sodium nitrite disappoints in cardiac arrest
April 16, 2020
The drug did not significantly improve patients’ chances of being admitted to or discharged from the hospital alive in a new study.
News
COVID-19 cases highlight longstanding racial disparities in health care
April 16, 2020
Data on higher infection and death rates in African Americans from COVID-19 may serve as a call to action.
News
Troponins touted as ‘ally’ in COVID-19 triage, but message is nuanced
April 14, 2020
A consequence of not measuring hs-cTn may be to “ignore the plethora of ischemic and nonischemic causes of myocardial injury related to COVID-19,” a U.K. team argues.
News
Cardiology groups push back on hydroxychloroquine, azithromycin for COVID-19
April 8, 2020
Both drugs are known to cause torsade de pointes and increase the risk of other arrhythmias, say the AHA, ACC, and HRS.
News
COVID-19 linked to multiple cardiovascular presentations
April 7, 2020
Temporary hemodynamic support is shown to help patients with cardiogenic shock, according to case studies.
News
New guidance on management of acute CVD during COVID-19
March 31, 2020
Expert guidance comes from Chinese cardiology and infectious disease specialists on how to manage severe emergent cardiovascular disease during COVID-19.
News
Dapagliflozin trial in CKD halted because of high efficacy
March 30, 2020
An independent data monitoring committee recommended stopping the trial.